A significant finding emerged when researchers revealed that the inhibition of tumor necrosis factor alpha (TNF-α) could effectively maintain LV function, all while ensuring the anti-cancer effects of anti-PD-1 therapy remain uncompromised. Here, PDCD1 is linked to cancer.